Celebrex (celecoxib) NDC 58151-083

NDC codes

FDA NDC Directory

Product NDC (as listed)58151-083Labeler and product segments. Claims need a package NDC.

Product NDC at billing width58151-0083Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
58151-083-01	58151008301	100 CAPSULE in 1 BOTTLE (58151-083-01)Marketed from Sep 13, 2024
58151-083-05	58151008305	500 CAPSULE in 1 BOTTLE (58151-083-05)Marketed from Sep 13, 2024
58151-083-88	58151008388	100 BLISTER PACK in 1 CARTON (58151-083-88) / 1 CAPSULE in 1 BLISTER PACK (58151-083-32)Marketed from Sep 17, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Celebrex
Generic name (nonproprietary): celecoxib
Active ingredients: Celecoxib — 100 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Viatris Specialty LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 020998
Marketing start: Sep 13, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 58151-083_0c321a7b-89e4-48cc-ab0b-1bd7620d7799SPL ID 0c321a7b-89e4-48cc-ab0b-1bd7620d7799SPL set ID 2d6675e4-5859-4be2-8037-a20ce9f707aaRxCUI 205322, 205323, 213468, 213469, 349514, 352314, 686379, 686381UNII JCX84Q7J1LUPC 0358151085910, 0358151084012, 0358151082919, 0358151083015
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N458151008301 followed by a unit qualifier and the quantity

Package 58151-0083-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 22, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

CELEBREX is indicated CELEBREX is a nonsteroidal anti-inflammatory drug indicated for: • Osteoarthritis (OA) ( 1.1 ) • Rheumatoid Arthritis (RA) ( 1.2 ) • Juvenile Rheumatoid Arthritis (JRA) in patients 2 years and older ( 1.3 ) • Ankylosing Spondylitis (AS) ( 1.4 ) • Acute Pain (AP) ( 1.5 ) • Primary Dysmenorrhea (PD) ( 1.6 ) 1.1 Osteoarthritis (OA) For the management of the signs and symptoms of OA [see Clinical Studies (14.1) ] . 1.2 Rheumatoid Arthritis (RA) For the management of the signs and symptoms of RA [see Clinical Studies (14.2) ] . 1.3 Juvenile Rheumatoid Arthritis (JRA) For the management of the signs and symptoms of JRA in patients 2 years and older [see Clinical Studies (14.3…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 020998

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 020998
Product	Strength	Form · route	Labeler	Product NDC
Celebrexcelecoxib	Celecoxib 200 mg/1	CapsuleOral	Viatris Specialty LLC	58151-084
Celebrexcelecoxib	Celecoxib 50 mg/1	CapsuleOral	Viatris Specialty LLC	58151-082
Celebrexcelecoxib	Celecoxib 400 mg/1	CapsuleOral	Viatris Specialty LLC	58151-085